China Pharma Holdings Balance Sheet Health
Financial Health criteria checks 1/6
China Pharma Holdings has a total shareholder equity of $6.5M and total debt of $4.0M, which brings its debt-to-equity ratio to 60.5%. Its total assets and total liabilities are $13.5M and $6.9M respectively.
Key information
60.5%
Debt to equity ratio
US$3.95m
Debt
| Interest coverage ratio | n/a |
| Cash | US$718.69k |
| Equity | US$6.53m |
| Total liabilities | US$6.94m |
| Total assets | US$13.47m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: XQJ's short term assets ($3.7M) do not cover its short term liabilities ($4.8M).
Long Term Liabilities: XQJ's short term assets ($3.7M) exceed its long term liabilities ($2.2M).
Debt to Equity History and Analysis
Debt Level: XQJ's net debt to equity ratio (49.5%) is considered high.
Reducing Debt: XQJ's debt to equity ratio has increased from 22.2% to 60.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XQJ has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: XQJ has less than a year of cash runway if free cash flow continues to reduce at historical rates of 38.5% each year